All studies
Cardiology · Claims · US
Stephan 2026
Heart failure with preserved ejection fraction
QBA performedPPSuperiorityAcademia4/5 disclosures
Comparisons
4
In the analysis
0
4 withheld
Target trials
1
Emulations reported
1
2 treatments
Design and methods
- Estimand
- PP
- Design hypothesis
- Superiority
- Matching / weighting
- Clone-censor-weight
- Analysis method
- IPCW pooled survival model
- Missing data
- Complete case
- Covariates adjusted
- 143
- DAG
- No
- QBA
- Yes
Data and sample
- Data type
- Claims
- Data sources
- 1
- Geography
- US
- Eligible sample
- 320881
- Treated
- Cloned strategy arm
- Control
- Cloned strategy arm
- Emulations
- 1
- Treatments compared
- 2
Transparency
- Protocol
- https://doi.org/10.17605/OSF.IO/6MNCF
- Preprint
- No preprint
- Data availability
- Unavailable
- Code availability
- https://osf.io/4rqbd
- Conflicts of interest
- Declared: Industry
- COI institutions
- Vertex; Boehringer Ingelheim; Aetion; other relationships reported in the manuscript
- Funding
- Declared: Public, Research institute
- Funders
- Deutsche Forschungsgemeinschaft project 532417373; internal Brigham and Harvard funding
The 0-5 count records which disclosures are present. It is not a quality score: a data link does not establish that the data are reusable.
Provenance
- Review key
- 2026_Stephan_TOPCAT
- DOI
- https://doi.org/10.1038/s43856-026-01796-z
- Affiliations
- Brigham and Women's Hospital; Harvard Medical School
- Sector
- Academia
- Target trials (study level)
- TOPCAT
- Registration
- NCT00094302